RNAC - Cartesian Therapeutics | Financials | Fundamentei

12/2022

2 financials

12/2023

Year	Revenue	EBITDA	Net Inc	Net Mrg	Equity	ROE	Net Debt	ND/EBITDA	OCF SBC	Capex	FCF	Free SBC	EPS
12/2022	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2023	26	-235	-220	L	-440	L	-66	-	-74	-0	-13	-74	L

To see all financials—including updated, you must be Premium.